As a pharmacist Sherif El-Refai pursued his doctorate in pharmaceutical sciences and also held a scientific background which included a period studying pharmacogenomics at the University of North Carolina. Pharmacogenomics is a subject that examined how genetic factors interact with medications. Many a times, when doctor prescribe drugs to a patient, they do so with the hope that those patients will respond similarly.
However, pharmacogenomics is based on the fact that each patient is unique and will therefore have different reaction to drugs, meaning some may exhibit strong or adverse reactions to medications while others experience no reaction at all. By searchi8ng pharmacogenomics, Sherif El-Refai hoped that one day individuals/patients will respond to specific drugs. There are many clinical trials using pharmacogenomics approaches that studies how people react to medications intended to treat conditions ranging from heart diseases to depression.
Ever since the Human Genome Project unlocked the code by which our bodies function, medical practitioners have pursued using the information to better provide care. This practice is known as pharmacogenomics and will become a staple of medical practice. Sherif El-Refai as an accomplished researcher and pharmacist helps to understand pharmacogenomics and individualized therapy that encompasses research from heart diseases to organ transplant and cancer treatments.